These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6486504)

  • 1. Clinical pharmacology of edrophonium in infants and children.
    Fisher DM; Cronnelly R; Sharma M; Miller RD
    Anesthesiology; 1984 Oct; 61(4):428-33. PubMed ID: 6486504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man.
    Morris RB; Cronnelly R; Miller RD; Stanski DR; Fahey MR
    Anesthesiology; 1981 May; 54(5):399-401. PubMed ID: 7224209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edrophonium-hyoscine butylbromide mixture for reversal of neuromuscular blockade: heart rate changes in infants and children.
    Yamashita M; Tajima K
    Anaesthesia; 1988 Jul; 43(7):591-3. PubMed ID: 3414927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.
    Hennis PJ; Cronnelly R; Sharma M; Fisher DM; Miller RD
    Anesthesiology; 1984 Nov; 61(5):534-9. PubMed ID: 6149707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edrophonium for the antagonism of neuromuscular blockade in dogs.
    Clutton RE
    Vet Rec; 1994 Jun; 134(26):674-8. PubMed ID: 7941276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropine-edrophonium mixture: a dose-response study.
    Naguib M; Gomaa M; Absood GH
    Anesth Analg; 1988 Jul; 67(7):650-5. PubMed ID: 3382038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study.
    Mirakhur RK
    Eur J Anaesthesiol; 1987 Nov; 4(6):411-9. PubMed ID: 3446491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine.
    Shorten GD; Ali HH; Goudsouzian NG
    Br J Anaesth; 1993 Feb; 70(2):160-2. PubMed ID: 8435259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.
    Fisher DM; O'Keeffe C; Stanski DR; Cronnelly R; Miller RD; Gregory GA
    Anesthesiology; 1982 Sep; 57(3):203-8. PubMed ID: 7114542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of pancuronium neuromuscular blockade in halothane-anesthetized ponies using neostigmine and edrophonium.
    Hildebrand SV; Howitt GA
    Am J Vet Res; 1984 Nov; 45(11):2276-80. PubMed ID: 6524720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response for atropine and heart rate in infants and children anesthetized with halothane and nitrous oxide.
    Palmisano BW; Setlock MA; Brown MP; Siker D; Tripuraneni R
    Anesthesiology; 1991 Aug; 75(2):238-42. PubMed ID: 1859012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and autonomic nervous effects of edrophonium and atropine combinations during neuromuscular blockade antagonism in sheep.
    Clutton RE; Glasby MA
    Vet Anaesth Analg; 2008 May; 35(3):191-200. PubMed ID: 18282258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine.
    Donati F; McCarroll SM; Antzaka C; McCready D; Bevan DR
    Anesthesiology; 1987 Apr; 66(4):471-6. PubMed ID: 3565812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfentanil in infants and children with congenital heart defects.
    den Hollander JM; Hennis PJ; Burm AG; Bovill JG
    J Cardiothorac Anesth; 1988 Feb; 2(1):12-7. PubMed ID: 2979128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.